Hirdes J.P, Maxwell C.J.  1994.  Smoking cessation and quality of life outcomes among older adults in the Campbell's Survey on Well-Being. Canadian Journal of Public Health Revue Canadienne de Sante Publique. 85(2):99-102.

Maxwell C.J, Campitelli M.A, Hogan D.B, Diong C., Austin P.C, Amuah J.E, Lapane K., Seitz D.P, Gill S.S, Gruneir A. et al..  2017.  Frailty, antipsychotics and mortality among community-based older adults with impaired cognition. Pharmacoepidemiology and Drug Safety. 26(Supplement 2):456-457.

Maxwell C.J, Hirdes J.P.  1993.  The prevalence of smoking and implications for quality of life among the community-based elderly. American Journal of Preventive Medicine. 9(6):338-45.

Neutel C.I, Hirdes J.P, Maxwell C.J, Patten S.B.  1996.  New evidence on benzodiazepine use and falls: the time factor. Age & Ageing. 25(4):273-8.

Vik S.A, Maxwell C.J, Hogan D.B, Patten S.B, Johnson J.A, Romonko-Slack L..  2005.  Assessing medication adherence among older persons in community settings. Canadian Journal of Clinical Pharmacology. 12(1):e152-e164.

Hogan D.B, Maxwell C.J, Dampf H., McGrail K., Estabrooks C.A, Poss J.W, Bakal J.A, Hoben M..  2024.  Excess Deaths in Assisted Living and Nursing Homes during the COVID-19 Pandemic in Alberta, Canada. J Am Med Dir Assoc. 25(7):105032.